Dulhunty AF - Search Results

1

How does flecainide impact RyR2 channel function?

Salvage SC, Huang CL, Fraser JA, Dulhunty AF. Salvage SC, et al. Among authors: dulhunty af. J Gen Physiol. 2022 Sep 5;154(9):e202213089. doi: 10.1085/jgp.202213089. Epub 2022 Jun 17. J Gen Physiol. 2022. PMID: 35713932 Free PMC article.

2

Noninactivating tension in rat skeletal muscle. Effects of thyroid hormone.

Chua M, Dulhunty AF. Chua M, et al. Among authors: dulhunty af. J Gen Physiol. 1989 Jul;94(1):183-203. doi: 10.1085/jgp.94.1.183. J Gen Physiol. 1989. PMID: 2809571 Free PMC article.

3

Single channel activity of the ryanodine receptor calcium release channel is modulated by FK-506.

Ahern GP, Junankar PR, Dulhunty AF. Ahern GP, et al. Among authors: dulhunty af. FEBS Lett. 1994 Oct 3;352(3):369-74. doi: 10.1016/0014-5793(94)01001-3. FEBS Lett. 1994. PMID: 7523191 Free article.

4

Effects of ivermectin and midecamycin on ryanodine receptors and the Ca2+-ATPase in sarcoplasmic reticulum of rabbit and rat skeletal muscle.

Ahern GP, Junankar PR, Pace SM, Curtis S, Mould JA, Dulhunty AF. Ahern GP, et al. Among authors: dulhunty af. J Physiol. 1999 Jan 15;514 ( Pt 2)(Pt 2):313-26. doi: 10.1111/j.1469-7793.1999.313ae.x. J Physiol. 1999. PMID: 9852316 Free PMC article.

5

What we don't know about the structure of ryanodine receptor calcium release channels.

Dulhunty AF, Pouliquin P. Dulhunty AF, et al. Clin Exp Pharmacol Physiol. 2003 Oct;30(10):713-23. doi: 10.1046/j.1440-1681.2003.03904.x. Clin Exp Pharmacol Physiol. 2003. PMID: 14516409 Review.

6

Calsequestrin and the calcium release channel of skeletal and cardiac muscle.

Beard NA, Laver DR, Dulhunty AF. Beard NA, et al. Among authors: dulhunty af. Prog Biophys Mol Biol. 2004 May;85(1):33-69. doi: 10.1016/j.pbiomolbio.2003.07.001. Prog Biophys Mol Biol. 2004. PMID: 15050380 Free article. Review.

7

Excitation-contraction coupling from the 1950s into the new millennium.

Dulhunty AF. Dulhunty AF. Clin Exp Pharmacol Physiol. 2006 Sep;33(9):763-72. doi: 10.1111/j.1440-1681.2006.04441.x. Clin Exp Pharmacol Physiol. 2006. PMID: 16922804 Review.

8

Structural and functional characterization of interactions between the dihydropyridine receptor II-III loop and the ryanodine receptor.

Casarotto MG, Cui Y, Karunasekara Y, Harvey PJ, Norris N, Board PG, Dulhunty AF. Casarotto MG, et al. Among authors: dulhunty af. Clin Exp Pharmacol Physiol. 2006 Nov;33(11):1114-7. doi: 10.1111/j.1440-1681.2006.04501.x. Clin Exp Pharmacol Physiol. 2006. PMID: 17042924

9

Agonists and antagonists of the cardiac ryanodine receptor: potential therapeutic agents?

Dulhunty AF, Beard NA, Pouliquin P, Casarotto MG. Dulhunty AF, et al. Pharmacol Ther. 2007 Feb;113(2):247-63. doi: 10.1016/j.pharmthera.2006.08.007. Epub 2006 Sep 16. Pharmacol Ther. 2007. PMID: 17055586 Review.

10

Muscle-specific GSTM2-2 on the luminal side of the sarcoplasmic reticulum modifies RyR ion channel activity.

Wei L, Abdellatif YA, Liu D, Kimura T, Coggan M, Gallant EM, Beard NA, Board PG, Dulhunty AF. Wei L, et al. Among authors: dulhunty af. Int J Biochem Cell Biol. 2008;40(8):1616-28. doi: 10.1016/j.biocel.2007.12.019. Epub 2008 Jan 20. Int J Biochem Cell Biol. 2008. PMID: 18308613

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

192 results

Search Page

Filters